These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 31246158

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The effects of sample handling and N-phenylmaleimide on concentration of adrenocorticotrophic hormone in equine plasma.
    Rendle DI, Litchfield E, Gough S, Cowling A, Hughes KJ.
    Equine Vet J; 2015 Sep; 47(5):587-91. PubMed ID: 24980684
    [Abstract] [Full Text] [Related]

  • 3. Investigation of rhythms of secretion and repeatability of plasma adrenocorticotropic hormone concentrations in healthy horses and horses with pituitary pars intermedia dysfunction.
    Rendle DI, Litchfield E, Heller J, Hughes KJ.
    Equine Vet J; 2014 Jan; 46(1):113-7. PubMed ID: 23742059
    [Abstract] [Full Text] [Related]

  • 4. The effect of freeze-thaw cycles on determination of immunoreactive plasma adrenocorticotrophic hormone concentrations in horses.
    Hu K, Stewart AJ, Yuen KY, Hinrichsen S, Dryburgh EL, Bertin FR.
    J Vet Intern Med; 2020 May; 34(3):1350-1356. PubMed ID: 32255541
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Evaluation of combined testing to simultaneously diagnose pituitary pars intermedia dysfunction and insulin dysregulation in horses.
    Horn R, Bertin FR.
    J Vet Intern Med; 2019 Sep; 33(5):2249-2256. PubMed ID: 31498947
    [Abstract] [Full Text] [Related]

  • 8. Adrenocorticotropin concentration following administration of thyrotropin-releasing hormone in healthy horses and those with pituitary pars intermedia dysfunction and pituitary gland hyperplasia.
    Beech J, Boston R, Lindborg S, Russell GE.
    J Am Vet Med Assoc; 2007 Aug 01; 231(3):417-26. PubMed ID: 17669045
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. BEVA primary care clinical guidelines: Diagnosis and management of equine pituitary pars intermedia dysfunction.
    Menzies-Gow NJ, Banse HE, Duff A, Hart N, Ireland JL, Knowles EJ, McFarlane D, Rendle D.
    Equine Vet J; 2024 Mar 01; 56(2):220-242. PubMed ID: 37795557
    [Abstract] [Full Text] [Related]

  • 11. Comparison of cortisol and ACTH responses after administration of thyrotropin releasing hormone in normal horses and those with pituitary pars intermedia dysfunction.
    Beech J, Boston R, Lindborg S.
    J Vet Intern Med; 2011 Mar 01; 25(6):1431-8. PubMed ID: 22092639
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of plasma ACTH, alpha-melanocyte-stimulating hormone, and insulin concentrations during various photoperiods in clinically normal horses and ponies and those with pituitary pars intermedia dysfunction.
    Beech J, Boston RC, McFarlane D, Lindborg S.
    J Am Vet Med Assoc; 2009 Sep 15; 235(6):715-22. PubMed ID: 19751169
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Venipuncture does not affect adrenocorticotropic hormone concentration in horses.
    Fouché N, van der Kolk JH, Bruckmaier RM, Luz I, Foerster G, Gerber V.
    Vet Rec; 2015 Sep 05; 177(9):223. PubMed ID: 26246396
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of two methods for measurement of equine adrenocorticotropin.
    Banse HE, Schultz N, McCue M, Geor R, McFarlane D.
    J Vet Diagn Invest; 2018 Mar 05; 30(2):233-237. PubMed ID: 29284383
    [Abstract] [Full Text] [Related]

  • 16. α-Melanocyte--stimulating hormone and adrenocorticotropin concentrations in response to thyrotropin-releasing hormone and comparison with adrenocorticotropin concentration after domperidone administration in healthy horses and horses with pituitary pars intermedia dysfunction.
    Beech J, McFarlane D, Lindborg S, Sojka JE, Boston RC.
    J Am Vet Med Assoc; 2011 May 15; 238(10):1305-15. PubMed ID: 21568777
    [Abstract] [Full Text] [Related]

  • 17. Correlation of pituitary histomorphometry with adrenocorticotrophic hormone response to domperidone administration in the diagnosis of equine pituitary pars intermedia dysfunction.
    Miller MA, Pardo ID, Jackson LP, Moore GE, Sojka JE.
    Vet Pathol; 2008 Jan 15; 45(1):26-38. PubMed ID: 18192571
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pharmacokinetic and pharmacodynamic properties of pergolide mesylate following long-term administration to horses with pituitary pars intermedia dysfunction.
    McFarlane D, Banse H, Knych HK, Maxwell LK.
    J Vet Pharmacol Ther; 2017 Apr 15; 40(2):158-164. PubMed ID: 27301465
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of basal plasma α-melanocyte-stimulating hormone and adrenocorticotrophic hormone concentrations for the diagnosis of pituitary pars intermedia dysfunction from a population of aged horses.
    Mc Gowan TW, Pinchbeck GP, Mc Gowan CM.
    Equine Vet J; 2013 Jan 15; 45(1):66-73. PubMed ID: 22563728
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.